someone explain small molecule to me like I have not read a paper in years
ACHIEVE. That is the whole post, but I will justify it. Everything else people worry about in c/survodutide is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort ACHIEVE out first, and almost nobody does. I say this having got it wrong for 20 months. My…
ATTAIN and ACHIEVE are phase 10 trials
What are you comparing it against though?
oral non-peptide agonist is ACHIEVE, no food restrictions
the fatigue profile is speculative at this stage
Has anyone actually got this in writing, or is it forum lore at this point?